Setback for CMA in £90m appeal case against big pharma
The Court of Appeal on Tuesday (March 10) upheld the Competition Appeal Tribunal's (CAT) 2018 decision to reject the CMA’s £90 million fine against Pfizer and Flynn Pharma.
The Court of Appeal on Tuesday (March 10) upheld the Competition Appeal Tribunal's (CAT) 2018 decision to reject the CMA’s £90 million fine against Pfizer and Flynn Pharma.